Improving the Quality of Dementia Care Through Innovative Redesign of the Memory Care Environment
Launched by MAYO CLINIC · Apr 14, 2020
Trial Information
Current as of October 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking for ways to improve the care provided to people living with dementia by changing their living environments. The goal is to find new and better ways to support the needs of individuals with dementia, making their daily lives more comfortable and fulfilling.
If you or a loved one currently lives in the Arbor Terrace memory care unit and has a dementia diagnosis, you might be eligible to participate in this study. It’s important to note that individuals who are in hospice care with less than 30 days to live cannot join the trial. Participants will be involved in activities that aim to enhance their care experience, and throughout the study, they will have the opportunity to share their thoughts and feelings about the changes being tested. This research hopes to make a positive impact on the quality of life for those living with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients currently residing at Arbor Terrace memory care unit
- • Patients diagnosed with dementia
- Exclusion Criteria:
- • Hospice patients with less than 30 days of life expectancy at the time of enrollment
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Ying Ying Chen, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials